Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update Mar 13, 2025
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025 Mar 5, 2025
Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference Feb 5, 2025
Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference Jan 12, 2025
Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring Dec 10, 2024
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update Nov 18, 2024
Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225 Nov 14, 2024
Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer Nov 12, 2024
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024 Nov 11, 2024
